Chemiesynth (Vapi) Limited (BSE: 539230) is a Mumbai, Maharashtra-based company in the Organic Dyes And Pigments industry. With a market capitalisation of ₹0 Cr, it ranks #5,225 by market cap among the 6,197 Indian listed companies on FinBizNet, and #18 of 19 in Organic Dyes And Pigments. At ₹160.70 (as of 16 Nov 2026), the share price is 0.0% below its 52-week high of ₹160.70 and 327.1% above its 52-week low of ₹37.63. The share price is up 327.1% over one year and up 97.9% over three months.
| Current Price | ₹160.70 |
|---|---|
| Market Cap | ₹0 Cr |
| BSE Code | 539230 |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Organic Dyes And Pigments |
| Return on Equity | -9.42% |
| Return on Assets | -3.08% |
| 52-Week Range | ₹37.63 – ₹160.70 |
| 1-Year Price Change | +327.1% |
| 3-Month Price Change | +97.9% |
| Beta (1Y) | -0.15 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.chemiesynth.com |
| Revenue | ₹4 Cr |
|---|---|
| Net Profit | ₹-1 Cr |
| Net Margin | -13.8% |
| EPS (Basic) | ₹1.90 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Chemiesynth (Vapi) Limited reported revenue of ₹4 Cr in Q1 FY27, up 5.8% from ₹4 Cr in Q1 FY26 and down 23.6% from ₹6 Cr in Q4 FY26. It posted a net loss of ₹1 Cr for the quarter, against a net loss of ₹0 Cr in Q1 FY26. Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹4 Cr (Q3 FY25) to ₹7 Cr (Q2 FY26). The company reported a net loss in 5 of these 8 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q1 FY27 | ₹4 Cr | −₹1 Cr | −13.8% |
| Q4 FY26 | ₹6 Cr | ₹1 Cr | 10.9% |
| Q3 FY26 | ₹5 Cr | −₹1 Cr | −13.8% |
| Q2 FY26 | ₹7 Cr | −₹0 Cr | −6.4% |
| Q1 FY26 | ₹4 Cr | −₹0 Cr | −11.6% |
| Q4 FY25 | ₹7 Cr | ₹0 Cr | 2.8% |
| Q3 FY25 | ₹4 Cr | −₹0 Cr | −12.1% |
| Q2 FY25 | ₹5 Cr | ₹0 Cr | 7.7% |
Standalone figures (₹ crore, XBRL filings).
Delivery averaged 100.0% of traded volume across 6 BSE sessions (21 Oct 2026 – 5 Nov 2026).
Chemiesynth (Vapi) Limited manufactures and sells dye intermediates and chemicals in India. The company offers fluorescent and solvent dyes products, as well as polyolefin additives dyes products to agro chemicals, pharmaceutical, photographic, and cosmetics industries. Chemiesynth (Vapi) Limited was incorporated in 1986 and is headquartered in Mumbai, India.
1. NA-NA 2. NA-NA 3. NA-NA 4. NA-NA
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Indokem Ltd. | ₹1,799 Cr | 956.7 | 2.93% | — | +24.9% |
| Plastiblends India Ltd. | ₹452 Cr | 12.3 | 8.37% | ₹229 Cr | -1.2% |
| Vipul Organics Ltd | ₹421 Cr | 57.7 | 7.62% | ₹52 Cr | +21.8% |
| Aksharchem (India) Ltd. | ₹295 Cr | n/m | -0.17% | ₹160 Cr | +40.1% |
| Dynemic Products Ltd. | ₹282 Cr | 14.2 | 8.49% | ₹127 Cr | -23.4% |
| Indian Toners & Developers Ltd. | ₹237 Cr | 8.6 | 12.55% | — | -16.3% |
| Jd Orgochem Ltd. | ₹213 Cr | 14.7 | 11.42% | — | -13.7% |
| Ishan Dyes & Chemicals Ltd. | ₹117 Cr | n/m | -5.78% | ₹20 Cr | -41.9% |
| Chemiesynth (Vapi) Limited | ₹0 Cr | — | -9.42% | ₹4 Cr | +327.1% |
Listed by market capitalisation. Ratios are shown for context only.
Chemiesynth (Vapi) Limited is trading at ₹160.70, with a market capitalisation of ₹0 Cr.
Chemiesynth (Vapi) Limited operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Organic Dyes And Pigments).
Chemiesynth (Vapi) Limited has a return on equity of -9.42%.
Chemiesynth (Vapi) Limited is listed on the BSE under the scrip code 539230.
Chemiesynth (Vapi) Limited's share price is up 327.1% over one year and up 97.9% over three months. Its 52-week range is ₹37.63 to ₹160.70.
In Q1 FY27, Chemiesynth (Vapi) Limited reported revenue of ₹4 Cr and net profit of ₹-1 Cr, with basic EPS of ₹1.9 (standalone, parsed from the company's exchange filing).
Chemiesynth (Vapi) Limited reported revenue of ₹4 Cr in Q1 FY27, up 5.8% from ₹4 Cr in Q1 FY26 and down 23.6% from ₹6 Cr in Q4 FY26.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.